Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Paris  >  Sartorius Stedim Biotech SA    STDM   FR0000053266

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Sales6848841 0521 1581 2701 411
EBITDA161231289320359406
Operating profit (EBIT)120185226262296344
Pre-Tax Profit (EBT)105170213254288336
Net income72,5139177181204240
P/E ratio34,239,031,234,230,626,3
EPS ( € )0,791,511,922,002,242,61
Dividend per Share ( € )0,220,330,420,440,640,59
Yield0,81%0,56%0,70%0,64%0,94%0,87%
Reference price ( € )26.883358.959.9768.4468.4468.44
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Finances - Leverage
Actuals in M € Estimates in M €
Fiscal Period December 201420152016201720182019
Debt87,486,459,078,233,748,0
Finance------
Operating income (EBITDA)161231289320359406
Leverage
(Debt/EBITDA)
0,54x0,37x0,20x0,24x0,09x0,12x
Capital Expenditure47,153,079,7107109103
Book Value Per Share (BVPS)5,78 €6,96 €8,22 €9,95 €11,7 €14,0 €
Cash Flow per Share1,21 €1,52 €1,70 €2,48 €2,83 €3,16 €
Announcement Date01/27/2015
04:00pm
02/01/2016
06:00am
01/30/2017
06:00am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 6 309 M€ -
Entreprise Value (EV) 6 387 M€ 6 342 M€
Valuation 2017e 2018e
P/E ratio (Price / EPS) 34,2x 30,6x
Capitalization / Revenue 5,45x 4,97x
EV / Revenue 5,51x 4,99x
EV / EBITDA 20,0x 17,7x
Yield (DPS / Price) 0,64% 0,94%
Price to book (Price / BVPS) 6,88x 5,83x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 22,6% 23,3%
operating Leverage (Delta EBIT / Delta Sales) 1,57x 1,33x
Net Margin (Net Profit / Revenue) 15,6% 16,0%
ROA (Net Profit / Asset) 12,5% 12,9%
ROE (Net Profit / Equities) 20,6% 19,6%
Rate of Dividend 22,0% 28,8%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   9,23% 8,61%
Cash Flow / Sales 19,7% 20,5%
Capital Intensity (Assets / Sales) 1,25x 1,24x
Financial Leverage (Net Debt / EBITDA) 0,24x 0,09x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend